Cambridge Healthtech Institute’s 5th Annual 

Global Site Selection, Feasibility Assessment,
Operations and Site Management
 

Improving Timelines and Outcomes with Strategy, Relationships, Data and Execution
February 24-25, 2015 | Hyatt Regency Orlando | Orlando, FL 


Dear Colleague:

I am pleased to announce production of CHI’s 5th Annual “Global Site Selection, Feasibility Assessment, Operations and Site Management” being held February 24-25, 2015 at the Hyatt Regency in Orlando, FL.

The gathering will be part of the 6th Annual Summit for Clinical Trials Operations Executives (SCOPE), a three-day cluster of events that attracted 700 leaders in clinical operations and research in February 2014. Please see the overall program map below for 2015.

Topics to be discussed at the “Global Site Selection, Feasibility Assessment, Operations and Site Management” conference include: 

  • Analyzing the market: Working with stakeholders early on to better identify the patient segment and improve protocol feasibility and planning
  • Employing trial design and protocol development strategies that support study site compliance: Minimize downstream operational challenges with good design
  • Site selection and study planning considerations: Understanding regional issues, regulatory landscapes, and local ethics processes
  • Optimizing country selection: Strategies for positioning trials for success using a global footprint
  • Optimizing the site feasibility process: Improving global site feasibility assessment to identify sites that will recruit on time and within budget
  • Understanding your protocol and its burden on your clin ops teams, sites and patients: Decide on patient cohort  and strategy early prior to going into tactics
  • Objective country feasibility and selection: Where are the patients?
  • Data-driven site selection: Understand the number of sites, their probability of success, and the impact of site non-performance
  • Cost-effective techniques for finding high performing sites: High-tech and low-tech solutions to avoid uninterested and low enrolling parties
  • Overcoming challenges in clinical operations and site management: Linking sponsors, service providers and investigative sites and positioning sites for success by anticipating their needs 
  • Improving operational efficiencies in Site, CRO, and Sponsor Interactions: Implementing Strategic Relationships and other forms of partnerships
  • Driving innovation in study start-up: Optimizing processes, training leaders and leveraging technology
  • Update on TransCelerate and other collaborations
  • Leveraging EMRs/EHRs to improve feasibility and recruitment

If you are interested in presenting, please click here to submit a speaking proposal for review.

Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academic /hospital centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

Deadline for submission is July 11, 2014. 

2015 Summit for Clinical Ops Executives (SCOPE) Conference at a Glance Large 

SCOPE 2014 Wrap-Up
Held February 4-6, 2014, in Miami, Florida, the 5th Annual SCOPE Summit gathered more than 700 industry leaders, an attendance increase of 18% from 2013, for three stimulating days of in-depth discussions covering important issues in clinical trial planning and management. With 11 different conference tracks, a Clinical Informatics News Best Practices Awards and two plenary keynote sessions, SCOPE offered advances and innovative solutions in all aspects of clinical trial management and operations, including Data Integration, Feasibility, Site Selection and Management, Recruitment and Retention, Social Media and Mobile Tech, Project Management, Forecasting, Aggregate Spend Compliance, Post-Marketing Studies, and Sample Logistics. The impressive executive audience at SCOPE came together for invaluable networking opportunities with more than 70% of the attendees titled as Executives from leading Pharma (16%), CRO (32%), and Biotech companies (26%). Industry leaders and key decision makers representing 16 different countries and more than 350 unique organizations shared case studies, collaborated on best practices and provided unique perspectives on poignant issues that the field currently faces.

For questions or suggestions about the meeting, please contact:
Micah Lieberman
Executive Director, Conferences
Cambridge Healthtech Institute (CHI)
T: (+1) 541.482.4709
E: mlieberman@healthtech.com 

 For partnering and sponsorship information, please contact:
Ilana Quigley
Manager, Business Development
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5457
E: iquigley@healthtech.com 

For media and association partnerships, please contact:
Rich Handy
Senior Director, Marketing
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5456
E: rhandy@healthtech.com 

About Cambridge Healthtech Institute (CHI)
Founded in 1992, Cambridge Healthtech Institute (CHI) (www.chicorporate.com) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Events, Pharmaceutical Strategy Series, Barnett International, Insight Pharma Reports, Marketing Services, and Cambridge Healthtech Media Group.


 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  


> Event-At-A-Glance
Event-At-A-Glance 

> Download 2014 Brochure
  2014 SCOPE Brochure Image 

> Premier Sponsors 

BBK
 

 ClinicalInk 

> View All Sponsors 

> View Media Partners 

> Attendee Profile